Login
| TI Ref No : | 524049304 |
|---|---|
| Description : | The Dak-gesundheit Is Seeking To Establish A Non-exclusive Discount Agreement For The Active Ingredient Aflibercept (excluding 114.3 Mg/ml) For The Period From December 1, 2025, To November 30, 2027. The Agreement Allows All Pharmaceutical Companies To En |
| Date : | 2025-10-18 |
| Deadline : | 2026-04-16 |
| Document Type : | Tenders |
